SPONSOR
Zhongnan Hospital
Total Trials
5
Recruiting
5
Phases
Phase 2
Conditions studied: PneumoniaFibroblast Activation Protein InhibitorPET/CTMalignant NeoplasmDry EyeCervical CancerAccuracy in Understanding the Core Content of English Medical Literature
Zhongnan Hospital is a clinical research sponsor with 5 registered studies on ClinicalTrials.gov, of which 5 are actively recruiting participants. Research covers conditions including Pneumonia, Fibroblast Activation Protein Inhibitor, PET/CT, Malignant Neoplasm.
The trial portfolio spans Phase 2 studies, reflecting a pipeline that may include early-stage safety evaluations, mid-stage efficacy assessments, and large-scale confirmatory trials. All studies listed here are sourced directly from ClinicalTrials.gov and updated daily.
Frequently Asked Questions — Zhongnan Hospital
How many clinical trials has Zhongnan Hospital sponsored?
ClinicalMetric currently tracks 5 clinical trials sponsored by Zhongnan Hospital, of which 5 are actively recruiting participants. These trials cover conditions including Pneumonia, Fibroblast Activation Protein Inhibitor, PET/CT. Trial counts are updated daily from ClinicalTrials.gov and reflect currently registered studies.
What therapeutic areas does Zhongnan Hospital research focus on?
Zhongnan Hospital clinical trials span Pneumonia, Fibroblast Activation Protein Inhibitor, PET/CT, Malignant Neoplasm, Dry Eye, and additional conditions. The research pipeline includes Phase 2 trials, reflecting work from early-stage safety evaluation through large-scale efficacy studies.
How do I participate in a Zhongnan Hospital clinical trial?
To participate in a Zhongnan Hospital trial, review the active studies listed on this page, check each trial's specific eligibility criteria on ClinicalTrials.gov, and contact the trial site directly—not the sponsor's headquarters. Trial sites are academic medical centers, hospitals, or specialized research clinics. Your physician can facilitate a referral. ClinicalMetric lists all Zhongnan Hospital trials with current recruitment status updated daily.
Clinical Trials by Zhongnan Hospital
NCT07453966
Recruiting
Efficacy and Safety of Intrapulmonary Percussive Ventilation in Patients With Pulmonary Infection Receiving Invasive Mechanical Ventilation
Pneumonia
NCT05034146
Recruiting
68Ga-FAPI PET/CT in Malignant Tumors
Fibroblast Activation Protein Inhibitor
NCT05632887
Recruiting
The Effect of Eyeliner on Tear Composition, Tear Secretion and Tear Film Stability.
Dry Eye
NCT05817214 Phase 2
Recruiting
Cadonilimab Plus Anlotinib for R/M/P Cervical Cancer
Cervical Cancer
NCT07460258
Recruiting
A Study on the Effect of Medical Students' Literature Reading Patterns on Cognitive Load and Academic Writing Ability
Accuracy in Understanding the Core Content of English Medical Literature
ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer · Last Reviewed: July 2026 · Data Methodology